<DOC>
	<DOC>NCT00596466</DOC>
	<brief_summary>This study will evaluate the long term safety and efficacy of pregabalin (Lyrica) when administered by itself (without any other anti-epileptic medication) to epilepsy patients for the treatment of partial seizures. This is an extension study to a previous clinical trial.</brief_summary>
	<brief_title>Extension Study Of Long-Term Safety And Efficacy Of Pregabalin As Monotherapy (Lyrica) In Patients With Partial Seizures</brief_title>
	<detailed_description />
	<mesh_term>Seizures</mesh_term>
	<mesh_term>Epilepsy</mesh_term>
	<mesh_term>Pregabalin</mesh_term>
	<criteria>Completed the previous protocol and wish to continue to receive pregabalin. Diagnosis of epilepsy with partial seizures Early withdrawal from the previous protocol, an episode of status epliepticus, or primary generalized epilepsy.</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>August 2012</verification_date>
	<keyword>open-label</keyword>
	<keyword>extension study</keyword>
	<keyword>pregabalin</keyword>
	<keyword>partial epilepsy</keyword>
</DOC>